The United States imports a significant portion of its finished pharmaceuticals, active pharmaceutical ingredients, and raw chemical components from a globally diversified network of manufacturing hubs. Major international suppliers include countries with advanced pharmaceutical infrastructure and large-scale manufacturing capacity, such as India and China (which supply vast quantities of generic active ingredients), alongside major European nations like Switzerland, Ireland, Germany, and the United Kingdom, which export specialized biologics and branded medications.